Israel Englander Organon & Co. Call Options Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$17.45 - $21.96 $4.34 Million - $5.46 Million	248,500 Added 457.64%	302,800 $6.27 Million
Q1 2024 May 15, 2024	SELL	$13.78 - $18.8 $629,746 - $859,160	-45,700 Reduced 45.7%	54,300 $1.02 Million
Q4 2023 Feb 14, 2024	SELL	$10.95 - $17.32 $552,975 - $874,660	-50,500 Reduced 33.55%	100,000 $1.44 Million
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $2.9 Million - $3.71 Million	150,500 New	150,500 $3.13 Million

793

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.